Sign in

CIK 0001213037

  • Non-accelerated filer
  • Smaller reporting company

Cardiff Oncology, Inc.

Sign in to watch
Ticker
CRDF
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
272004382
Phone
+1 858-952-7570
Business address
11055 FLINTKOTE AVENUE, SAN DIEGO, CA, 92121
Former names
Trovagene, Inc., TrovaGene Inc., XENOMICS INC, USED KAR PARTS INC
  1. 4 Open-market buy Chief Executive Officer bought 6,993 shares at $1.43 ($10,000)
  2. 4 Open-market buy Director bought 20,979 shares at $1.43 ($30,000)
  3. 4 Open-market buy Director bought 6,993 shares at $1.43 ($10,000)
  4. 4 Open-market buy Director bought 17,483 shares at $1.43 ($25,001)
  5. 4 Open-market buy Director bought 69,930 shares at $1.43 ($100,000)
  6. 4 Open-market buy Director bought 10,490 shares at $1.43 ($15,001)
  7. 4 Open-market buy Director bought 13,986 shares at $1.43 ($20,000)
  8. 4 Open-market buy Director bought 447,761 shares at $1.34 ($600,000)
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 3 Insider Initial Statement of Ownership
  13. 3 Insider Initial Statement of Ownership
  14. 3 Insider Initial Statement of Ownership
  15. 4 Shares withheld for taxes Chief Scientific Officer gave up 116 shares (to pay taxes)
  16. 4 Shares withheld for taxes Chief Scientific Officer gave up 552 shares (to pay taxes)
  17. 4 Shares withheld for taxes Chief Scientific Officer gave up 466 shares (to pay taxes)
  18. 4 Shares withheld for taxes Chief Scientific Officer gave up 461 shares (to pay taxes)
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 7 of 15 · 300 filings